Cancer Vaccine: Merck and Moderna Report Breakthrough in Melanoma Trial
A personalized mRNA vaccine combined with Keytruda reduced the risk of melanoma returning and spreading, raising hopes for treatment of ...
Read moreDetailsA personalized mRNA vaccine combined with Keytruda reduced the risk of melanoma returning and spreading, raising hopes for treatment of ...
Read moreDetailsImroze Pakistan is your trusted digital news platform, delivering timely and credible updates from across Pakistan and around the globe. From breaking headlines to insightful features on politics, economy, society, and international affairs — we aim to inform, engage, and empower our readers with facts that matter.
© 2025 Imroze Pakistan - All Rights Reserved
© 2025 Imroze Pakistan - All Rights Reserved